207 related articles for article (PubMed ID: 21471751)
21. Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer.
Guillem JG; Moore HG; Akhurst T; Klimstra DS; Ruo L; Mazumdar M; Minsky BD; Saltz L; Wong WD; Larson S
J Am Coll Surg; 2004 Jul; 199(1):1-7. PubMed ID: 15217621
[TBL] [Abstract][Full Text] [Related]
22. Neither FDG-PET Nor CT can distinguish between a pathological complete response and an incomplete response after neoadjuvant chemoradiation in locally advanced rectal cancer: a prospective study.
Guillem JG; Ruby JA; Leibold T; Akhurst TJ; Yeung HW; Gollub MJ; Ginsberg MS; Shia J; Suriawinata AA; Riedel ER; Mazumdar M; Saltz LB; Minsky BD; Nash GM; Paty PB; Temple LK; Weiser MR; Larson SM
Ann Surg; 2013 Aug; 258(2):289-95. PubMed ID: 23187748
[TBL] [Abstract][Full Text] [Related]
23. (18)F-Fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) for the early detection of response to neoadjuvant chemotherapy for locally advanced rectal cancer.
Nishimura J; Hasegawa J; Ogawa Y; Miwa H; Uemura M; Haraguchi N; Hata T; Yamamoto H; Takemasa I; Mizushima T; Nezu R; Doki Y; Mori M
Surg Today; 2016 Oct; 46(10):1152-8. PubMed ID: 26711129
[TBL] [Abstract][Full Text] [Related]
24. Optimal timing for assessment of tumor response to neoadjuvant chemoradiation in patients with rectal cancer: do all patients benefit from waiting longer than 6 weeks?
Perez RO; Habr-Gama A; São Julião GP; Gama-Rodrigues J; Sousa AH; Campos FG; Imperiale AR; Lynn PB; Proscurshim I; Nahas SC; Ono CR; Buchpiguel CA
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1159-65. PubMed ID: 22580120
[TBL] [Abstract][Full Text] [Related]
25. (18)F-fluorodeoxyglucose positron emission tomography immediately after chemoradiotherapy predicts prognosis in patients with locoregional postoperative recurrent esophageal cancer.
Jingu K; Kaneta T; Nemoto K; Takeda K; Ogawa Y; Ariga H; Koto M; Sakayauchi T; Takai Y; Takahashi S; Yamada S
Int J Clin Oncol; 2010 Apr; 15(2):184-90. PubMed ID: 20217449
[TBL] [Abstract][Full Text] [Related]
26. Restaging after neoadjuvant chemoradiotherapy for rectal adenocarcinoma: role of F18-FDG PET.
Capirci C; Rubello D; Chierichetti F; Crepaldi G; Carpi A; Nicolini A; Mandoliti G; Polico C
Biomed Pharmacother; 2004 Oct; 58(8):451-7. PubMed ID: 15464875
[TBL] [Abstract][Full Text] [Related]
27. Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy.
Arredondo J; Baixauli J; Beorlegui C; Arbea L; Rodríguez J; Sola JJ; Chopitea A; Hernández-Lizoáin JL
Dis Colon Rectum; 2013 Apr; 56(4):416-21. PubMed ID: 23478608
[TBL] [Abstract][Full Text] [Related]
28. PET-based treatment response evaluation in rectal cancer: prediction and validation.
Janssen MH; Öllers MC; van Stiphout RG; Riedl RG; van den Bogaard J; Buijsen J; Lambin P; Lammering G
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):871-6. PubMed ID: 21377810
[TBL] [Abstract][Full Text] [Related]
29. Semiquantitative Volumetry by Sequential PET/CT May Improve Prediction of Complete Response to Neoadjuvant Chemoradiation in Patients With Distal Rectal Cancer.
Dos Anjos DA; Perez RO; Habr-Gama A; São Julião GP; Vailati BB; Fernandez LM; de Sousa JB; Buchpiguel CA
Dis Colon Rectum; 2016 Sep; 59(9):805-12. PubMed ID: 27505108
[TBL] [Abstract][Full Text] [Related]
30. FDG-PET in the prediction of pathologic response after neoadjuvant chemoradiotherapy in locally advanced, resectable esophageal cancer.
Song SY; Kim JH; Ryu JS; Lee GH; Kim SB; Park SI; Song HY; Cho KJ; Ahn SD; Lee SW; Shin SS; Choi EK
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1053-9. PubMed ID: 15964705
[TBL] [Abstract][Full Text] [Related]
31. Comparison of (18)F-FDG PET/CT methods of analysis for predicting response to neoadjuvant chemoradiation therapy in patients with locally advanced low rectal cancer.
Altini C; Niccoli Asabella A; De Luca R; Fanelli M; Caliandro C; Quartuccio N; Rubini D; Cistaro A; Montemurro S; Rubini G
Abdom Imaging; 2015 Jun; 40(5):1190-202. PubMed ID: 25348731
[TBL] [Abstract][Full Text] [Related]
32. Optimal Interval for
Kawai K; Nozawa H; Hata K; Tanaka T; Nishikawa T; Oba K; Watanabe T
Clin Colorectal Cancer; 2018 Jun; 17(2):e163-e170. PubMed ID: 29208445
[TBL] [Abstract][Full Text] [Related]
33. The role of dual-time combined 18-fluorodeoxyglucose positron emission tomography and computed tomography in the staging and restaging workup of locally advanced rectal cancer, treated with preoperative chemoradiation therapy and radical surgery.
Capirci C; Rubello D; Pasini F; Galeotti F; Bianchini E; Del Favero G; Panzavolta R; Crepaldi G; Rampin L; Facci E; Gava M; Banti E; Marano G
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1461-9. PubMed ID: 19419820
[TBL] [Abstract][Full Text] [Related]
34. Early FDG PET response assessment of preoperative radiochemotherapy in locally advanced rectal cancer: correlation with long-term outcome.
Avallone A; Aloj L; Caracò C; Delrio P; Pecori B; Tatangelo F; Scott N; Casaretti R; Di Gennaro F; Montano M; Silvestro L; Budillon A; Lastoria S
Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1848-57. PubMed ID: 23053320
[TBL] [Abstract][Full Text] [Related]
35. Textural Parameters of Tumor Heterogeneity in ¹⁸F-FDG PET/CT for Therapy Response Assessment and Prognosis in Patients with Locally Advanced Rectal Cancer.
Bundschuh RA; Dinges J; Neumann L; Seyfried M; Zsótér N; Papp L; Rosenberg R; Becker K; Astner ST; Henninger M; Herrmann K; Ziegler SI; Schwaiger M; Essler M
J Nucl Med; 2014 Jun; 55(6):891-7. PubMed ID: 24752672
[TBL] [Abstract][Full Text] [Related]
36. Impact of post-therapy positron emission tomography on prognostic stratification and surveillance after chemoradiotherapy for cervical cancer.
Siva S; Herschtal A; Thomas JM; Bernshaw DM; Gill S; Hicks RJ; Narayan K
Cancer; 2011 Sep; 117(17):3981-8. PubMed ID: 21365626
[TBL] [Abstract][Full Text] [Related]
37. Prediction of survival and cancer recurrence using metabolic volumetric parameters measured by 18F-FDG PET/CT in patients with surgically resected rectal cancer.
Jo HJ; Kim SJ; Lee HY; Kim IJ
Clin Nucl Med; 2014 Jun; 39(6):493-7. PubMed ID: 24806602
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of qualitative response assessment interpretation criteria at 18F-FDG PET-CT for predicting outcome in locally advanced cervical carcinoma treated with chemoradiotherapy.
Scarsbrook A; Vaidyanathan S; Chowdhury F; Swift S; Cooper R; Patel C
Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):581-588. PubMed ID: 27738729
[TBL] [Abstract][Full Text] [Related]
39. Tumor response and survival predicted by post-therapy FDG-PET/CT in anal cancer.
Schwarz JK; Siegel BA; Dehdashti F; Myerson RJ; Fleshman JW; Grigsby PW
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):180-6. PubMed ID: 17996387
[TBL] [Abstract][Full Text] [Related]
40. Metabolic response on post-therapy FDG-PET predicts patterns of failure after radiotherapy for cervical cancer.
Schwarz JK; Siegel BA; Dehdashti F; Grigsby PW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):185-90. PubMed ID: 22014958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]